Aptose Biosciences Announces Arrangement Agreement for Acquisition by Hanmi Pharmaceutical
Aptose Biosciences minority shareholders to receive C$2.41 in cash per share in a "go private" transaction SAN DIEGO and TORONTO, Nov. 19, 2025 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. ("Aptose" or the "Company") (TSX: APS; OTC: APTOF) and Hanmi Pharmaceuti
(Financial Post, 2025-11-19T06:26:03Z)